The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent manner
Article in Frontiers in Endocrinology (July 2024)
The most recent citing publications are shown below. View all 204 publications that cite this research output on Dimensions.
Article in Frontiers in Endocrinology (July 2024)
Article in Cell Metabolism (July 2024)
Article in Neuroscience & Biobehavioral Reviews (April 2024)